David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA

home / authors / david-e-koren-pharmd-mph-bcps-aahivp-fidsa

Koren is a pharmacist specialist at Temple University health system and adjunct assistant clinical professor at the Lewis Katz School of Medicine at Temple University in Philadelphia, PA.

Articles

An Update on Lenacapavir

An Update on Lenacapavir

T. Sam Albanesi, MD, MA;David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA
June 9th 2023

This new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.

Read More

Preparing for the Next Long-acting Antiretrovirals

Preparing for the Next Long-acting Antiretrovirals

Valencia Oglesby, DO;David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA
December 27th 2022

Clinicians can make room for infrequent treatment options as patients enjoy their daily lives.

Read More

Site Logo

How Close Are We to a Cure for HIV?

Della Xu, PharmD;David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA
June 11th 2020

Evolving research has led the infectious diseases community to redefine its definition of cure.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance
Published: March 9th 2022 | Updated: December 22nd 2024
Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance
COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population
Published: December 5th 2024 | Updated: December 22nd 2024
COVID-19 Therapy Roundtable: What is the Virus Today, Treatment Options, and Addressing the Pediatric Population
COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?
Published: December 19th 2024 | Updated: December 22nd 2024
COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?
Peer-Assisted Telemedicine Enables More People With Hepatitis C to Get into the Continuum of Care
Published: December 17th 2024 | Updated: December 22nd 2024
Peer-Assisted Telemedicine Enables More People With Hepatitis C to Get into the Continuum of Care
Ethical and Innovative Use of AI in Infectious Disease
Published: December 18th 2024 | Updated: December 22nd 2024
Ethical and Innovative Use of AI in Infectious Disease
© 2024 MJH Life Sciences

All rights reserved.